Manhattan Research study finds that physicians want to conduct the majority
of their pharmaceutical research and information access online
NEW YORK, Aug. 14 /PRNewswire/ -- Physicians report that they will shift a significant amount of time currently devoted to offline professional sources to their online counterparts in the coming years, according to the just released ePharma Physician(R) study by pharmaceutical and healthcare market research company Manhattan Research.
The study and its accompanying advisory service focus on physician usage and opinions of online pharmaceutical and biotech information and feature data on a broad spectrum of life sciences companies including Merck, AstraZeneca, Novartis, Biogen, Astellas, Daiichi Sankyo, Sepracor, and Eisai.
This year's survey found that physicians desire to receive the majority of their pharmaceutical and device product information through online and other electronic sources. Currently, physicians conduct 41% of their pharmaceutical research online, but expect to increase that percentage to over 50% in the near future.
"This trend could prove to be an opportunity for smaller and targeted specialty pharmaceutical and biotech companies to gain ground on larger competitors in physician reach and market share through cost effective digital sales and marketing support strategies," says Mark Bard, Manhattan Research President. "Digital channels have leveled the playing field in many industries, giving sales and marketing groups the chance to make a big impact even with limited -- yet targeted -- resources."
Online journals and virtual conferences are two other professional
resources that should see spikes in physician traffic in the coming years.
The study found that physicians expect to shift time spent with print
journals and live conferences to those online counterparts. The market for
online clinical resources has been growing steadily over the past five
years, and some
|SOURCE Manhattan Research|
Copyright©2008 PR Newswire.
All rights reserved